As accumulation of wild type and mutant α-synuclein is pathogenic in PD and a feature of familial PD and other α-synucleinopathies, compounds that reduce the level of α-synuclein may alleviate and prevent the occurrence of Parkinsonism phenotypes. The gene discussed is SNCA; the disease is Parkinson disease.